Should I Stay?

Quote
If you stay, know the following:
1. you will be launching the drug the az way.
2. You will be part of an expande sales force..and that sales force will be built out with lots of overlaps/redundancy and the sales expansion will be augmented with legacy cvmd folks.
Pay attention to this! ..brilinta patent expires soon...threat of an entry as early as 2019...but for certain 2021..it will be game over for brilinta. Nothing else meaningful in the CV portion of the pipeline at AZ...so get ready for all of your az brilinta counterparts to becoming your cardio renal counterparts...and in the not so distant future.
 








anonymous said:
If you stay, know the following:
1. you will be launching the drug the az way.
2. You will be part of an expande sales force..and that sales force will be built out with lots of overlaps/redundancy and the sales expansion will be augmented with legacy cvmd folks.
Pay attention to this! ..brilinta patent expires soon...threat of an entry as early as 2019...but for certain 2021..it will be game over for brilinta. Nothing else meaningful in the CV portion of the pipeline at AZ...so get ready for all of your az brilinta counterparts to becoming your cardio renal counterparts...and in the not so distant future.
Click to expand...
This is true. If you launch the drug exclusively, it won’t be for long. That’s a big IF.
 




anonymous said:
If you stay, know the following:
1. you will be launching the drug the az way.
2. You will be part of an expande sales force..and that sales force will be built out with lots of overlaps/redundancy and the sales expansion will be augmented with legacy cvmd folks.
Pay attention to this! ..brilinta patent expires soon...threat of an entry as early as 2019...but for certain 2021..it will be game over for brilinta. Nothing else meaningful in the CV portion of the pipeline at AZ...so get ready for all of your az brilinta counterparts to becoming your cardio renal counterparts...and in the not so distant future.
Click to expand...


Totally in accurate information. CV specialty are not going to be coming to the renal cardio side in abundance. And I am in leadership and had to respond to this because it’s just absolutely false.
 








Top Bottom
Back
Quote